Open-label Extension Study in Participants With Early Alzheimer's Disease

Clinical trial NCT07105709 · RECRUITING

Trial details

NCT number: NCT07105709
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2025-08-14
Primary completion: 2028-09-15
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.